Saffron does show genuine antidepressant effects in clinical trials, and the evidence is stronger than for most herbal supplements. A 2024 meta-analysis of eight randomized controlled trials found no significant difference between saffron and standard SSRI antidepressants in reducing depressive symptoms. That doesn’t mean saffron is a proven replacement for medication, but it does mean it’s more than a folk remedy.
What the Clinical Trials Show
Most saffron depression research uses a standardized extract at 30 mg per day, taken as two 15 mg doses. In placebo-controlled trials, people taking saffron consistently scored better on the Hamilton Depression Rating Scale, which clinicians use to measure depression severity. In one trial, the saffron group improved nearly twice as much as the placebo group. A meta-analysis pooling these placebo-controlled results found a large effect size of 1.62, which is considered clinically meaningful.
The more striking finding comes from head-to-head comparisons with prescription antidepressants. When researchers compared saffron directly to fluoxetine (the generic name for Prozac), the outcomes were statistically equivalent. People taking saffron experienced similar reductions in depression scores over six to eight weeks, with a comparable rate of side effects. These trials focused on mild to moderate depression, not severe cases.
How Saffron Affects Your Brain
Saffron contains three active compounds that influence mood. The first, crocin, is a potent antioxidant found in the stigma (the red threads). It affects serotonin and dopamine, the same neurotransmitter systems targeted by prescription antidepressants. Crocin also appears to protect brain cells from stress-related damage and helps keep neurotransmitter levels balanced by blocking the production of harmful metabolites.
The second compound, safranal, is what gives saffron its distinctive smell. It has both antidepressant and anti-anxiety properties, working on similar neurotransmitter pathways. The third, crocetin, supports memory and cognitive function, which often suffer during depressive episodes. Together, these compounds also reduce inflammation in the brain, a process increasingly linked to depression.
Dosage Used in Research
The standard dose across nearly all clinical trials is 30 mg per day of saffron extract, split into two doses. This applies to both stigma (thread) and petal extracts, as both have been tested. Some trials used 15 mg twice daily alongside an SSRI and found that saffron amplified the antidepressant effect without adding significant side effects. Trial durations ranged from four to eight weeks, with most lasting six weeks.
This 30 mg dose is far less than the amount you’d use cooking. A pinch of saffron threads in a paella contains a fraction of what’s in a concentrated extract capsule. The clinical research uses standardized supplements with verified levels of crocin and safranal, not culinary saffron.
How Long Before It Works
Most trials measured outcomes at six weeks, though one four-week study also found significant improvement. This timeline is roughly comparable to conventional antidepressants, which typically take two to six weeks to reach full effect. You shouldn’t expect noticeable changes in the first week or two. In one postpartum depression trial, about 41% of women taking saffron experienced a complete response (defined as a 50% or greater reduction in depression scores) by the six-week mark, compared to 50% taking fluoxetine. That gap was not statistically significant.
Side Effects and Safety
At the standard 30 mg daily dose, saffron’s side effect profile is mild. The most commonly reported effects across trials include nausea, headache, anxiety, appetite changes (both increases and decreases), and occasional sedation or drowsiness. These are similar in type and frequency to what’s seen with SSRIs, though saffron tends to cause fewer sexual side effects, which are a common complaint with conventional antidepressants.
At therapeutic doses, saffron shows no toxic effects on the liver, kidneys, thyroid, or blood clotting system. One study specifically tested saffron tablets at 200 and 400 mg per day for one week and found no adverse effects on coagulation. However, at the higher 400 mg dose (well above the therapeutic range), researchers did observe a decrease in standing blood pressure and changes in some blood markers, including kidney function values. Sticking to 30 mg per day avoids these issues entirely.
Pregnant women should avoid high-dose saffron supplements. Animal studies have shown embryonic effects at high doses, and while normal culinary amounts appear safe, there isn’t enough clinical data to confirm the safety of concentrated extracts during pregnancy.
Saffron for Postpartum Depression
One double-blind trial specifically tested saffron in women aged 18 to 45 with mild to moderate postpartum depression. Women received either 15 mg of saffron twice daily or 20 mg of fluoxetine twice daily for six weeks. Depression scores improved at the same rate in both groups, and the frequency of side effects was similar. The researchers concluded saffron may be a safe alternative for postpartum depressive symptoms, though this remains a single study and larger trials are needed.
Important Limitations
Nearly all of the clinical research on saffron and depression comes from Iran, where saffron is widely cultivated and culturally significant. This raises questions about whether the results would hold up in more diverse populations. Sample sizes have been small, typically 30 to 40 participants per trial. And the research has focused exclusively on mild to moderate depression. There is no evidence supporting saffron as a treatment for severe or treatment-resistant depression.
Supplement quality is another concern. Saffron is the world’s most expensive spice by weight, which creates a market for adulterated products. If you’re considering a saffron supplement, look for one that specifies its crocin and safranal content and has been independently tested for purity. A supplement that simply lists “saffron” without standardization may contain too little of the active compounds to have any effect.